These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2891555)

  • 1. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
    Lokhandwala MF; Watkins HO; Dlewati A
    Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
    Van der Niepen P; Lefebvre RA; Dupont AG
    J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
    Lokhandwala MF; Kivlighn SD; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA; Valocik RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart.
    Dlewati A; Watkins HO; Lokhandwala MF
    Eur J Pharmacol; 1989 May; 164(2):197-203. PubMed ID: 2569408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
    Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
    Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
    Van der Niepen P; Schoors DF; Dupont AG
    Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF; Sabouni MH
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I; Thiry C; Pratz J; Lawson K
    Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD; Glock D; Goldberg LI
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
    J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
    Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.
    Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
    Eur J Pharmacol; 1985 Dec; 118(3):321-9. PubMed ID: 2867915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.